Fierce Pharma

APRIL 11, 2024

As lawmakers, biopharma companies and others try to stabilize vulnerable pharma supply chains, drug shortages have become about as bad as they’ve ever been in the U.S. | The American Society of Health-System Pharmacists has released new data showing there were 323 drugs in shortage in the U.S. as of 2024’s first quarter—the highest number recorded since ASHP began tracking shortage data back in 2001.

Biopharma 328

Biopharma Pharma 328

Dominic Tyer

APRIL 11, 2024

Online changes pose some pressing questions for the industry and demand a new approach to websites and data

Pharma 130

Pharma Pharmaceutical Marketing 130

Fierce Pharma

APRIL 11, 2024

After investigations into the FDA’s response to severe drug shortages and other issues, the House Committee on Oversight and Accountability finally had its long-awaited chance to grill the agency’s | FDA Commissioner Robert Califf, M.D., told lawmakers that the agency, as the "referee," needs to be given more authority in order to preemptively halt drug shortages.

FDA 317

FDA 317

MedCity News

APRIL 11, 2024

Following an extensive investigative report from the New York Times, the AHA is calling for the Labor Department to probe into the business practices of data analytics firm MultiPlan. The report revealed that MultiPlan works with major payers to negotiate reduced reimbursements for out-of-network medical providers — and this that practice ends up costing patients and employers.

Networking 124

Networking Medical Patients 124

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

APRIL 11, 2024

The U.S. government is accusing Regeneron of deliberately using an unusual method to overcharge Medicare for the company’s popular eye drug Eylea. | The U.S. government is accusing Regeneron of deliberately using an unusual method to overcharge Medicare for the company’s popular eye drug Eylea.

Government 306

Government 306

MedCity News

APRIL 11, 2024

Grow Therapy’s $88 million Series C funding round was led by Sequoia Capital. The financing will help the company invest in its team, improve its product and expand its footprint. The post Grow Therapy Secures $88M To Expand Mental Health Services appeared first on MedCity News.

124

124

MedCity News

APRIL 11, 2024

Novartis gains global rights to an Arvinas protein degrading drug that targets the androgen receptor to treat prostate cancer. The deal also includes a preclinical molecule addressing an androgen receptor variant. The post Novartis Pays $150M to Nab a Phase 3-Ready Protein Degrader for Prostate Cancer appeared first on MedCity News.

Biopharma 124

Biopharma Pharma 124

Fierce Pharma

APRIL 11, 2024

As the contract manufacturing industry stands at a crossroads, certain CDMOs are prospering while other stalwarts are going the sell-off route or warding off political and economic threats to their | Fujifilm Diosynth is investing $1.2 billion more to soup up its end-to-end biomanufacturing facility in Holly Springs, North Carolina, bringing the total project to more than $3.2 billion, the company said Thursday.

Manufacturing 246

Manufacturing 246

PharmaTimes

APRIL 11, 2024

RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR

Prescription 121

Prescription Medical 121

Fierce Pharma

APRIL 11, 2024

Geopolitical tensions are casting uncertainties over cross-border biotech deals. | Geopolitical tensions are casting uncertainties over cross-border biotech deals. Johnson & Johnson and Legend Biotech's Carvykti, plus AstraZeneca and Daiichi Sankyo's Enhertu, secured new FDA approvals. Fujifilm is making a big investment in its facility in North Carolina.

Pharma 232

Pharma FDA 232

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

APRIL 11, 2024

Roche and Eli Lilly have been granted breakthrough status by the FDA for their pTau217 blood test for Alzheimer's disease.

FDA 119

FDA 119

PharmaTech

APRIL 11, 2024

The draft guidance provides recommendations for data integrity for clinical and bioanalytical portions of bioavailability and bioequivalence studies submitted with drug applications.

FDA 116

FDA 116

MedCity News

APRIL 11, 2024

As the healthcare evolves toward service-based models, providers increasingly look to balance service delivery demands while keeping their core medical values without yielding to an overburdened system’s pressures. The post A Guide for Specialty Practices Navigating a Future of Healthcare that Does Good and Feels Good appeared first on MedCity News.

Healthcare 115

Healthcare Healthcare Medical 115

pharmaphorum

APRIL 11, 2024

Novartis accelerates its protein degrader programmes by licensing a phase 3-ready prostate cancer candidate from Arvinas in a deal worth over $1 billion

115

115

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

European Pharmaceutical Review

APRIL 11, 2024

Expirations of biologic patents has enabled manufacturers to enter the market and offer lower-cost alternatives of these drugs, [which has] resulted in increased competition and price pressure, driving the growth of the biosimilar market” A report published by Towards Healthcare has estimated that the global biosimilar market will value $1,26,019.67 million by 2032, at 17.6 percent CAGR between 2023 and 2032.

Marketing 105

Marketing Competition Manufacturing Medicine 105

pharmaphorum

APRIL 11, 2024

The European Parliament has voted through reforms to legislation regulating the pharma sector, which the industry claims could compromise competitiveness and patient care.

Pharma 105

Pharma Competition Patients 105

European Pharmaceutical Review

APRIL 11, 2024

The pharmaceutical industry is becoming increasingly conscious of emissions and the importance of sustainable manufacturing. Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. 1 That’s more than the automotive sector, which released 46.4 megatonnes in the same year, and the increased demand and complexity of medicines since then will only have swollen this figure. 1 Every major pharmaceutical manufact

Manufacturing 105

Manufacturing Pharmaceutical Engineering Pharmaceutical manufacturing 105

pharmaphorum

APRIL 11, 2024

US files a lawsuit against Regeneron, accusing the pharma company of fraudulent price reporting for ophthalmology drug Eylea

Pharma 105

Pharma 105

Advertisement

Pharmaceutical Commerce

APRIL 11, 2024

The latest news for pharma industry insiders.

Pharma 105

Pharma Medicine 105

pharmaphorum

APRIL 11, 2024

AbbVie’s Aquipta has become the first oral therapy for chronic and episodic migraine prevention to be recommended by NICE for NHS use.

105

105

Pharmaceutical Technology

APRIL 11, 2024

The oral drug, which gained UK approval in September 2023, is used for the prevention of both chronic and episodic migraines.

97

97

PharmaTimes

APRIL 11, 2024

Prostate cancer is responsible for around 12,000 deaths a year in the UK and is the second biggest cause of death for men

Leads 97

Leads 97

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

European Pharmaceutical Review

APRIL 11, 2024

A new clinical study has demonstrated that when administered immediately post-childbirth, one low dose injection of esketamine reduced major depressive episodes in individuals with prenatal depression. Based on the data, the researchers concluded that low dose esketamine should be considered in mothers with symptoms of prenatal depression. In mothers with prenatal depressive symptoms , a single low dose of esketamine given shortly after childbirth decreased major depressive episodes at 42 days p

Safety 95

Safety Pharmaceutical Patients 95

PharmaTech

APRIL 11, 2024

In this exclusive Drug Digest video interview, Felicity Thomas, Europe/senior editor, Pharmaceutical Technology Group, interviews Dr. Krizia M. Karry, Global Head of Technical Marketing for BASF Pharma Solutions, on the topic of hot melt extrusion.

Pharma 69

Pharma Pharmaceutical Marketing 69

Pharmaceutical Commerce

APRIL 11, 2024

Companies striving for transformed and targeted growth are exploring strategies that include partnerships, artificial intelligence, increased efficiencies, and competitive intelligence.

Pharma 59

Pharma Competition 59

MedCity News

APRIL 11, 2024

Share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health, healthcare navigation, and more. The post Health Benefit Consultants, Share Your Expert Insights in Our Survey appeared first on MedCity News.

Consulting 59

Consulting Healthcare Healthcare 59

Advertisement

Distribution

Pharmaceutical Technology

APRIL 11, 2024

Alpine’s lead asset, povetacicept, is slated to enter Phase III trials in the second half of this year.

Pharma 59

Pharma Leads 59

MedCity News

APRIL 11, 2024

This is a test of an excerpt. Test test test. Test testtesttest. Test The post Testing post publishing appeared first on MedCity News.

Specialization 59

Specialization Retail Medical Biopharma 59

Salesforce

APRIL 11, 2024

Dispatch management is the process that helps your dispatchers schedule, manage, and track the resources needed for field service requests. Our research finds that 72% of consumers say they’ll remain most loyal to the companies that provide faster service. That’s a lot of pressure for your dispatchers who must make sure every customer gets the right help when they want it.

Management 59

Management Insurance Healthcare Healthcare 59

Pharmacy Times

APRIL 11, 2024

The antibody drug conjugate was used in combination with the anti-cancer drug SG3249, and demonstrated efficacy in mouse models after 1 week.

55

55

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales